Active	Status	Sponsor type	Region	Phase	Filter
1 Active 7 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hubatsch, Doug
Denali, NCT04630808: MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension	Active, not recruiting	3	696	US, RoW	NCX 470 0.1%, NCX 470, Latanoprost 0.005%, Latanoprost	Nicox Ophthalmics, Inc.	Open Angle Glaucoma, Ocular Hypertension	03/25	07/25
Stapper, Robert
No trials found
Doan, Long
No trials found